BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12139454)

  • 1. Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.
    Müller CE; Thorand M; Qurishi R; Diekmann M; Jacobson KA; Padgett WL; Daly JW
    J Med Chem; 2002 Aug; 45(16):3440-50. PubMed ID: 12139454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.
    Ozola V; Thorand M; Diekmann M; Qurishi R; Schumacher B; Jacobson KA; Müller CE
    Bioorg Med Chem; 2003 Feb; 11(3):347-56. PubMed ID: 12517430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA
    J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists.
    Vu CB; Kiesman WF; Conlon PR; Lin KC; Tam M; Petter RC; Smits G; Lutterodt F; Jin X; Chen L; Zhang J
    J Med Chem; 2006 Nov; 49(24):7132-9. PubMed ID: 17125265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
    Kim YC; Ji X; Melman N; Linden J; Jacobson KA
    J Med Chem; 2000 Mar; 43(6):1165-72. PubMed ID: 10737749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Merighi S; Varani K; Borea PA
    J Med Chem; 2005 Jul; 48(14):4697-701. PubMed ID: 16000006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists.
    Hess S; Müller CE; Frobenius W; Reith U; Klotz KN; Eger K
    J Med Chem; 2000 Nov; 43(24):4636-46. PubMed ID: 11101355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists.
    Sauer R; Maurinsh J; Reith U; Fülle F; Klotz KN; Müller CE
    J Med Chem; 2000 Feb; 43(3):440-8. PubMed ID: 10669571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(3)H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([(3)H]PSB-11), a novel high-affinity antagonist radioligand for human A(3) adenosine receptors.
    Müller CE; Diekmann M; Thorand M; Ozola V
    Bioorg Med Chem Lett; 2002 Feb; 12(3):501-3. PubMed ID: 11814828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
    Minetti P; Tinti MO; Carminati P; Castorina M; Di Cesare MA; Di Serio S; Gallo G; Ghirardi O; Giorgi F; Giorgi L; Piersanti G; Bartoccini F; Tarzia G
    J Med Chem; 2005 Nov; 48(22):6887-96. PubMed ID: 16250647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.
    Drabczyńska A; Yuzlenko O; Köse M; Paskaleva M; Schiedel AC; Karolak-Wojciechowska J; Handzlik J; Karcz T; Kuder K; Müller CE; Kieć-Kononowicz K
    Eur J Med Chem; 2011 Sep; 46(9):3590-607. PubMed ID: 21664729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists.
    Priego EM; von Frijtag Drabbe Kuenzel J; IJzerman AP; Camarasa MJ; Pérez-Pérez MJ
    J Med Chem; 2002 Aug; 45(16):3337-44. PubMed ID: 12139445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.
    Gao ZG; Melman N; Erdmann A; Kim SG; Müller CE; IJzerman AP; Jacobson KA
    Biochem Pharmacol; 2003 Feb; 65(4):525-34. PubMed ID: 12566079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives.
    Gao ZG; Kim SG; Soltysiak KA; Melman N; IJzerman AP; Jacobson KA
    Mol Pharmacol; 2002 Jul; 62(1):81-9. PubMed ID: 12065758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts.
    Brackett LE; Daly JW
    Biochem Pharmacol; 1994 Mar; 47(5):801-14. PubMed ID: 8135856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
    Yan L; Müller CE
    J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New substituted 9-alkylpurines as adenosine receptor ligands.
    Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective A(3) adenosine receptor antagonists: water-soluble 3, 5-diacyl-1,2,4-trialkylpyridinium salts and their oxidative generation from dihydropyridine precursors.
    Xie R; Li AH; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1999 Oct; 42(20):4232-8. PubMed ID: 10514293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.